Nosebleeds: Labs, Causes, and Next Steps

Why Nosebleeds Happen: Anterior vs. Posterior Bleeding

The vast majority of nosebleeds start from a coin-sized vascular patch on the lower anterior septum called the Kiesselbach plexus, where four small arteries converge beneath thin mucosa. A 2020 retrospective analysis of 2,405 epistaxis presentations at a UK emergency department found that 90 to 95% were anterior in origin, self-limited, and manageable with direct pressure alone [1]. Posterior bleeds are different. They arise from branches of the sphenopalatine artery, produce higher-volume hemorrhage, and drain down the throat rather than out the nostril.

Distinguishing anterior from posterior matters because the workup and treatment diverge sharply. An anterior bleed in a 25-year-old during a dry winter usually requires nothing beyond moisturizing and gentle nasal care. A posterior bleed in a 68-year-old on apixaban may require packing, lab work, and a hospital admission. The American Academy of Otolaryngology's 2020 clinical practice guideline emphasizes that clinicians should document bleed laterality, estimate volume, and assess hemodynamic stability before deciding on intervention [2].

Age is a reliable sorting variable. Children between 2 and 10 bleed anteriorly almost without exception. Adults over 50, especially those with hypertension or on blood thinners, make up the bulk of posterior epistaxis cases that need procedural management [3].

Common Causes of Recurrent Nosebleeds

Dry air and mechanical trauma account for the majority of cases. Digital manipulation (nose-picking) remains the single most frequent trigger in both children and adults, per a 2018 survey published in Rhinology [4]. Low indoor humidity during winter months dries the nasal mucosa, creating cracks in the epithelium that expose superficial capillaries.

Beyond dryness and trauma, several medical conditions drive recurrent episodes:

Hypertension. Sustained blood pressure above 140/90 mmHg does not cause nosebleeds directly, but it makes them harder to stop and more likely to recur. A prospective study of 764 patients presenting with epistaxis to a Swiss emergency department found that 47% had undiagnosed or poorly controlled hypertension at the time of the bleed [5].

Coagulopathies. Von Willebrand disease (VWD), the most common inherited bleeding disorder, affects roughly 1% of the population and frequently presents first as recurrent childhood nosebleeds. A 2019 study in Blood Advances reported that epistaxis was the initial symptom in 62% of VWD diagnoses made before age 18 [6].

Hereditary hemorrhagic telangiectasia (HHT). This autosomal dominant vascular disorder causes abnormal blood vessel formation throughout the body. Recurrent nosebleeds beginning in adolescence are the hallmark feature, occurring in over 90% of affected individuals by age 21 according to the Second International HHT Guidelines published in Annals of Internal Medicine [7].

Allergic and chronic rhinitis. Persistent inflammation weakens mucosal integrity. Frequent nose-blowing during allergy season compounds the mechanical stress.

Medications. Anticoagulants (warfarin, apixaban, rivarelbane), antiplatelet agents (aspirin, clopidogrel), and intranasal corticosteroid sprays all raise the risk. The ROCKET AF trial (N=14,264) documented epistaxis in 10.1% of rivaroxaban-treated patients versus 8.6% on warfarin over a median follow-up of 1.9 years [8].

When Nosebleeds Signal Something Serious

A single brief nosebleed is rarely dangerous. The red flags that warrant same-day medical evaluation include bleeding that lasts longer than 20 minutes despite continuous pinching, estimated blood loss exceeding 250 mL (roughly one cup), bilateral simultaneous bleeding, posterior drainage causing persistent swallowing or gagging, and hemodynamic changes such as lightheadedness, tachycardia, or syncope.

Recurrence also matters. The American Academy of Otolaryngology guideline defines "recurrent epistaxis" as four or more distinct episodes within a four-week window, and this threshold should prompt laboratory evaluation and ENT referral [2]. In children, frequent nosebleeds paired with easy bruising, heavy menstrual periods, or prolonged bleeding after dental extractions raise suspicion for VWD or platelet function disorders [6].

Dr. David Gudis, Chief of the Division of Rhinology at Columbia University Irving Medical Center, has stated: "Any adult who develops new-onset recurrent epistaxis after age 50, particularly if they are not on anticoagulants, needs endoscopic examination to rule out a sinonasal mass."

Rarely, recurrent unilateral nosebleeds can be the presenting sign of a nasal or nasopharyngeal malignancy. A 2021 case series in The Laryngoscope found that 3.2% of adults referred to ENT for refractory unilateral epistaxis had an underlying neoplasm identified on nasal endoscopy [9].

The Diagnostic Workup: Labs Your Doctor Should Order

For a first isolated anterior nosebleed in an otherwise healthy person, lab testing is unnecessary. Once episodes become recurrent, heavy, or difficult to stop, a focused panel provides critical diagnostic information.

Tier 1: Baseline labs for all recurrent epistaxis

• Complete blood count (CBC) with differential. This screens for thrombocytopenia (platelet count below 150,000/mcL), anemia from chronic blood loss, and hematologic malignancies. A platelet count under 50,000/mcL significantly increases bleeding risk [10].
• Prothrombin time (PT) and international normalized ratio (INR). These evaluate the extrinsic coagulation pathway and are mandatory for any patient on warfarin. Target INR for most indications is 2.0 to 3.0; epistaxis risk climbs steeply above 3.5 [8].
• Activated partial thromboplastin time (aPTT). This screens the intrinsic pathway and will be prolonged in hemophilia A and B, though it may be normal in mild VWD.
• Basic metabolic panel (BMP). Renal dysfunction (BUN, creatinine) causes platelet dysfunction through uremic toxins. Liver disease (often reflected in low albumin) impairs synthesis of clotting factors.

Tier 2: Directed testing based on clinical suspicion

• Von Willebrand factor (VWF) antigen and activity (ristocetin cofactor), plus factor VIII level. Order when the history suggests a bleeding diathesis: lifelong heavy periods, easy bruising, or family history of bleeding. VWD type 1 accounts for 70 to 80% of cases and is often missed on initial screening because VWF levels fluctuate with stress, exercise, and estrogen status [6].
• Platelet function assay (PFA-100). This is more sensitive than bleeding time for detecting qualitative platelet defects.
• Liver function tests (AST, ALT, bilirubin, albumin). Chronic liver disease reduces production of factors II, V, VII, IX, and X.
• Thyroid-stimulating hormone (TSH). Hypothyroidism is associated with acquired VWD in rare cases, and hyperthyroidism can increase mucosal vascularity.

Tier 3: Specialty-level testing

• Genetic testing for HHT (ENG, ACVRL1, SMAD4 mutations) when the Curacao criteria are met: recurrent epistaxis, mucocutaneous telangiectasias, visceral AVMs, and a first-degree relative with HHT [7].
• Factor XIII activity, if all other studies are normal but bleeding persists. Factor XIII deficiency is rare (1 in 2 million) but easily missed by standard coagulation panels.

A 2017 consensus statement from the International Society on Thrombosis and Haemostasis recommended that any patient with a bleeding score of 4 or higher (males) or 6 or higher (females) on the ISTH Bleeding Assessment Tool undergo a full coagulation workup including VWF studies [11].

Imaging and Specialist Referral

Lab work alone does not visualize the bleeding source. Nasal endoscopy performed by an otolaryngologist is the standard method for identifying the precise vessel, ruling out masses, and assessing mucosal health. The procedure takes 5 to 10 minutes, uses topical anesthesia, and provides a direct view of both the anterior and posterior nasal cavity.

Computed tomography (CT) of the sinuses without contrast is indicated when endoscopy reveals a mass, polyp, or bony erosion, or when the bleeding source remains unidentifiable after adequate examination [2]. Magnetic resonance imaging (MRI) with gadolinium is preferred if a soft-tissue neoplasm or vascular malformation is suspected.

CT angiography (CTA) of the external and internal carotid arteries becomes relevant in two scenarios: refractory posterior epistaxis requiring possible embolization, and suspected pseudoaneurysm of the sphenopalatine or internal carotid artery after trauma or surgery. Interventional radiology consultation for selective arterial embolization has a success rate of 88 to 98% for intractable posterior epistaxis, according to a meta-analysis of 1,309 patients published in Clinical Otolaryngology [12].

When to see an ENT specifically:

• Four or more nosebleeds in a month
• Any posterior bleed
• Nosebleed requiring emergency department packing
• Unilateral recurrence without an obvious cause
• Suspected HHT (telangiectasias on lips, tongue, or fingertips)
• Failed conservative management after 4 to 6 weeks

First-Line Treatment: Stopping a Nosebleed at Home

The correct technique is simple but widely performed wrong. Sit upright and lean slightly forward. This is not optional. Leaning back sends blood down the pharynx, causes nausea, and makes it impossible to estimate blood loss. Pinch the soft, fleshy part of the nose (not the bony bridge) firmly between thumb and index finger. Hold for a full, uninterrupted 10 to 15 minutes by the clock.

Oxymetazoline 0.05% nasal spray (Afrin) applied to a cotton ball and inserted into the bleeding nostril before pinching adds topical vasoconstriction and reduces time to hemostasis. A randomized trial of 122 anterior epistaxis patients in the American Journal of Emergency Medicine found that oxymetazoline-soaked pledgets achieved hemostasis in 65% of patients within 10 minutes versus 35% with dry cotton alone [13].

After the bleeding stops:

• Apply a thin layer of petroleum jelly (Vaseline) or saline gel to the anterior septum twice daily for 2 to 4 weeks.
• Use a cool-mist humidifier in the bedroom if indoor humidity is below 40%.
• Avoid nose-blowing, heavy lifting, and hot beverages for 24 hours.
• Do not pack the nose with tissue paper, which adheres to clots and restarts bleeding on removal.

Dr. Stacey Gray, Director of the Sinus Center at Massachusetts Eye and Ear, has noted: "The single most effective preventive measure for anterior epistaxis in dry climates is consistent, twice-daily application of an emollient to the nasal septum. Patients who do this reliably reduce their recurrence rate by more than half."

Medical and Procedural Treatments

When home measures fail, medical and procedural options escalate in a predictable sequence.

Chemical cauterization. Silver nitrate sticks applied to an identified anterior bleeding point in the office setting is the most common minor procedure for recurrent anterior epistaxis. Bilateral septal cauterization at the same session is avoided because it raises the risk of septal perforation. Success rates for unilateral silver nitrate cautery range from 70 to 85% at 4-week follow-up [2].

Electrocautery. For vessels that do not respond to silver nitrate or for posterior sources visualized on endoscopy, bipolar electrocautery under endoscopic guidance provides more precise coagulation. This is typically performed in the office or outpatient surgical setting under local anesthesia.

Nasal packing. Anterior packs using absorbable materials (oxidized cellulose, gelatin sponge) or inflatable balloon devices (Rapid Rhino) tamponade the bleeding vessel mechanically. Posterior packing with a double-balloon catheter or Foley catheter is reserved for posterior hemorrhage and requires hospital admission for airway monitoring. A 2018 Cochrane review found no clear superiority of any one packing material over another, though dissolvable packs reduced patient discomfort on removal [14].

Tranexamic acid. This antifibrinolytic agent stabilizes clots at the bleeding site. A key randomized controlled trial (NoPAC, N=496) published in Annals of Emergency Medicine in 2020 showed that topical tranexamic acid (500 mg soaked into a cotton pledget) stopped anterior epistaxis in 73.4% of patients within 30 minutes compared to 68.7% with standard nasal packing [15]. Oral tranexamic acid (1,000 mg three times daily for 5 days) is used for recurrent HHT-related epistaxis and has shown a 54% reduction in epistaxis severity scores in a crossover trial [7].

Arterial ligation and embolization. Endoscopic sphenopalatine artery ligation (ESPAL) is the definitive surgical option for refractory posterior epistaxis, with success rates of 92 to 98% [12]. Selective embolization via interventional radiology is an alternative when surgical access is difficult or the patient is a poor surgical candidate.

Medications That Increase Nosebleed Risk

If you take any of the following medications and experience recurrent nosebleeds, discuss the risk-benefit balance with your prescriber. Never stop an anticoagulant without medical guidance.

Anticoagulants. Warfarin, apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa) all increase epistaxis frequency. The RE-LY trial (N=18,113) comparing dabigatran to warfarin for atrial fibrillation reported epistaxis rates of 11.7% (dabigatran 150 mg) versus 13.8% (warfarin) over 2 years [16].

Antiplatelet agents. Aspirin (even at 81 mg daily) and clopidogrel (Plavix) impair platelet aggregation. Dual antiplatelet therapy roughly doubles the epistaxis risk compared to monotherapy [8].

Intranasal corticosteroids. Fluticasone (Flonase), mometasone (Nasonex), and budesonide (Rhinocort) cause mucosal atrophy and capillary fragility with prolonged use. Directing the spray laterally toward the ear (away from the septum) reduces this risk. A 12-month study of 1,106 patients on intranasal corticosteroids found an epistaxis incidence of 17% with septal-directed spray versus 5% with laterally directed technique [4].

Herbal supplements. Ginkgo biloba, garlic extract, fish oil at doses above 3 g/day, and vitamin E above 400 IU/day all have antiplatelet or mild anticoagulant properties. These are frequently missed in medication reconciliation.

Nosebleeds in Children vs. Adults

Pediatric epistaxis is overwhelmingly anterior and benign. The peak incidence window is ages 2 to 10, driven by digital trauma, URI-related inflammation, and the relative prominence of Kiesselbach vessels in small noses. A large population-based study in Pediatrics (N=2,317) found that 30% of children aged 5 to 10 had at least one nosebleed in the preceding 12 months [17].

Parental anxiety often outstrips clinical severity. Most pediatric episodes last under 5 minutes and require nothing beyond the pinch-and-lean technique. However, children with VWD are frequently misdiagnosed for years. The mean time from first symptom to VWD diagnosis in pediatric patients is 4.6 years, per a 2019 registry analysis [6]. Any child with recurrent epistaxis combined with easy bruising, gum bleeding, or a family history of a bleeding disorder should have VWF antigen and activity levels drawn.

In adults over 50, the clinical calculus shifts. Posterior bleeds become more common. Anticoagulant use is prevalent. Atherosclerotic changes stiffen arterial walls, preventing normal vasoconstriction after vessel injury. The combination of age, hypertension, and anticoagulation creates a triple-risk profile that explains why adults over 70 are hospitalized for epistaxis at six times the rate of adults under 50 [3].

Your Next Steps: A Clear Action Plan

The right response depends on where you fall on the severity spectrum.

For infrequent, self-limited anterior nosebleeds: Apply petroleum jelly to both sides of the nasal septum every morning and before bed for 4 weeks. Run a humidifier if indoor humidity drops below 40%. Track episodes in a simple log (date, duration, estimated volume, nostril). No labs are needed unless the pattern changes.

For recurrent episodes (4 or more in a month): Schedule a primary care visit. Request a CBC, PT/INR, aPTT, and BMP at minimum. Bring your nosebleed log. Mention all medications, including over-the-counter aspirin, NSAIDs, and supplements. If the labs return normal and bleeds continue, ask for an ENT referral for nasal endoscopy.

For suspected bleeding disorder: Request VWF antigen, VWF activity, factor VIII level, and a PFA-100. These tests are sensitive to timing. VWF levels are lowest in the morning and in individuals with blood type O. A single normal result does not exclude VWD; repeat testing may be warranted [6].

For any posterior bleed or hemodynamic instability: Go to the emergency department. Posterior epistaxis requires professional packing, monitoring, and often admission. Do not attempt to manage posterior bleeds at home.

The threshold for lab testing is lower than many patients expect. A basic coagulation panel (CBC, PT/INR, aPTT) costs $45 to $120 without insurance and takes 24 hours to result. For recurrent epistaxis, this simple screen catches thrombocytopenia, supratherapeutic anticoagulation, and liver-synthetic dysfunction, which together account for the majority of identifiable systemic causes [10].